We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Samsung and Bracco Enter Into New Diagnostic Ultrasound Technology Agreement

By MedImaging International staff writers
Posted on 20 Mar 2024
Print article
Image: Samsung Medison CEO Mr. Yongkwan Kim and Bracco Imaging CEO Dr. Fulvio Renoldi Bracco endorsed a MoU agreement (Photo courtesy of Bracco Group)
Image: Samsung Medison CEO Mr. Yongkwan Kim and Bracco Imaging CEO Dr. Fulvio Renoldi Bracco endorsed a MoU agreement (Photo courtesy of Bracco Group)

Samsung Medison (Seoul, South Korea) and Bracco Imaging (Milan, Italy) have entered into a Memorandum of Understanding (MoU) agreement to pioneer a new area for diagnostic ultrasound devices and contrast agents. This MoU aims to create synergy in research and development and market exploration by combining the techniques and marketing capabilities of Samsung Medison and Bracco Imaging. Both companies are considering collaborative research to develop protocols for high-frequency and super-resolution imaging for diagnostic purposes. Samsung Medison is among the world's leading manufacturers of innovative premium ultrasound diagnostic equipment while Bracco Imaging is an innovative global leader delivering end-to-end products and solutions through a comprehensive portfolio that includes precision diagnostic imaging modalities. The two companies are considering collaborative research to develop protocols for high-frequency and super-resolution imaging for diagnostic purposes.

This agreement will also focus on global marketing activities including educating healthcare providers, jointly participating in strategic events, and exploring the possibilities in ultrasound-targeted contrast-enhanced drug delivery technologies in association with pharmaceutical agents. Samsung Medison and Bracco Imaging will collaborate on research to diversify the use of ultrasound contrast agents and enhance image resolution in various settings and specialties. Both companies aim to translate device features into diagnostic and clinical benefits for users and patients, including workflow. Bracco Imaging will integrate its quantitative diagnostic analysis software with Samsung Medison's diagnostic ultrasound equipment to improve image reporting and convenience for medical staff.

"Through this MoU agreement with Bracco and global collaboration, we will strengthen our capability in diagnostic ultrasound field, and create an opportunity to enter future ultrasound treatment field," said Yongkwan Kim, CEO of Samsung Medison. "We are planning to increase diagnostic accuracy and expand applicable scope based on Samsung Medison's various ultrasound clinical application techniques and AI solutions."

"It is truly exciting to usher in a new era of contrast agent utilization through our collaboration with Samsung Medison," added Fulvio Renoldi Bracco, CEO of Bracco Imaging. "I am optimistic that this agreement will lead to groundbreaking technological advances in practical treatment applications that will benefit our patients."

New
Gold Member
X-Ray QA Meter
T3 AD Pro
Portable X-ray Unit
AJEX130HN
New
3T MRI Scanner
MAGNETOM Cima.X
New
Mobile Barrier
Tilted Mobile Leaded Barrier

Print article
Radcal

Channels

Radiography

view channel
Image: The CT scanner prototype eliminates the need for physical compression of the breast (Photo courtesy of Quion Lowe and Lisa Dahm/U of A Cancer Center)

Novel Breast Cancer Screening Technology Could Offer Superior Alternative to Mammogram

Breast cancer represents 15.5% of new cancer cases and 7% of cancer-related deaths in the United States. Approximately 13.1% of women will be diagnosed with breast cancer during their lifetime.... Read more

Ultrasound

view channel
Image: Wearable ultrasound device offers continuous, long-term monitoring of muscle activity (Photo courtesy of Muyang Lin/UC San Diego)

Wearable Ultrasound Device Provides Long-Term, Wireless Muscle Monitoring

Electromyography (EMG) is the current clinical standard for monitoring muscle activity, utilizing metal electrodes placed on the skin to capture electrical signals from muscles. Despite its long-standing... Read more

Nuclear Medicine

view channel
Image: PET scans of a glioblastoma patient\'s brain, 72 hours after injection with the radiotracer (Photo courtesy of Dr Gabriela Kramer-Marek, The Institute of Cancer Research, London)

New Immuno-PET Imaging Technique Identifies Glioblastoma Patients Who Would Benefit from Immunotherapy

Glioblastoma is a type of brain tumor associated with a very poor prognosis, with average survival rates of 12 to 18 months and only 5% of patients surviving beyond five years. Research has shown that... Read more

General/Advanced Imaging

view channel
Image: Heavy smokers can ben Image (2):	efit from lung cancer screening using low-dose CT (Photo courtesy of 123RF)

Low-Dose CT Screening for Lung Cancer Can Benefit Heavy Smokers

Lung cancer is often diagnosed at a late stage, with only about one-fifth to one-sixth of patients surviving five years after diagnosis. A new report now suggests that low-dose computed tomography (CT)... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.